Search results
Memantine, sold under the brand name Namenda among others, is a medication used to slow the progression of moderate-to-severe Alzheimer's disease. [10] [11] [8] It is taken by mouth. [10] [8] Common side effects include headache, constipation, sleepiness, and dizziness. [10] [11] Severe side effects may include blood clots, psychosis, and heart ...
Memantine Mylan - działanie, wskazania, dawkowanie, przeciwwskazania, interakcje, refundacja, cena. Lek o działaniu przeciw glutaminergicznym, stosowny w chorobie Alzheimera.
Memantine is an NMDA receptor antagonist used to treat moderate to severe dementia in Alzheimer's. Brand Names. Axura, Ebixa, Marixino, Namenda, Namenda 49 Titration Pack, Namzaric. Generic Name. Memantine. DrugBank Accession Number. DB01043. Background.
Memantine is used to treat the symptoms of Alzheimer's disease (AD; a brain disease that slowly destroys the memory and the ability to think, learn, communicate and handle daily activities). Memantine is in a class of medications called NMDA receptor antagonists.
31 sty 2024 · Memantine is an uncompetitive antagonist of the NMDA subtype of glutamate receptors in the CNS. Alzheimer disease is believed to be caused by overstimulation of glutamate, the primary excitatory amino acid in the CNS, resulting in excitotoxicity and neuronal degeneration.
Memantine is used to treat moderate to severe Alzheimer's disease. Memantine is not a cure for Alzheimer's disease but it can help people with the disease. Memantine will not cure Alzheimer's disease, and it will not stop the disease from getting worse.
